Warning letters, 483s, Recalls, Import Alerts, Audit observations
Aurobindo’s Eugia Pharma Specialities Limited (FEI 3011960448), located at Shameerpet, India, has been classified OAI
USFDA Inspection of Pharmathen’s Rodopi facility in Greece (FEI 3009961173) resulted in issuance of Form
The USFDA has classified Sun Pharma’s Baska (Halol) facility (FEI: 3002957541) as Official Action Indicated
The USFDA has escalated the OAI (Official Action Indicated) classification of the Novo Nordisk–owned Catalent
The Warning letter (dated November 17, 2023) follows the FDA inspection at Cipla’s Pithampur, Indore
The USFDA Warning letter to K. C. Pharmaceuticals issued in August 2023, following inspection at
